Stay updated on Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Sign up to get notified when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.

Latest updates to the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page
- Check4 days agoChange DetectedThe new screenshot shows minor UI/layout adjustments to the study page. Core content such as the study title, NCT number, sponsor, eligibility criteria, enrollment numbers, and primary outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check33 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference4%

- Check40 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has been updated to include new drug information and related medical topics, while removing some previous drug names and related conditions. The facility name and location details have also been added.SummaryDifference7%

Stay in the know with updates to Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.